Torray LLC – BMRN history
- Issuer:
- BioMarin Pharmaceuticals
- Quarters tracked:
- 43 (Q3 2014 → Q2 2026)
- Current shares:
- 77,705
- Current value:
- $4.45M
- Peak shares:
- 448,000 (Q1 2016)
- Overall change:
- -78%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q2 2026 | 77,705 | $4.45M | $57.22 | -465 | -1% |
| Q1 2026 | 78,170 | $4.42M | $56.49 | +78,170 | +100% |
| Q3 2024 | SOLD | — | — | -16,855 | -100% |
| Q2 2024 | 16,855 | $1.39M | $82.35 | +2,019 | +14% |
| Q1 2024 | 14,836 | $1.30M | $87.36 | +168 | +1% |
| Q4 2023 | 14,668 | $1.41M | $96.40 | +446 | +3% |
| Q3 2023 | 14,222 | $1.26M | $88.45 | +3,241 | +30% |
| Q2 2023 | 10,981 | $952K | $86.70 | +104 | +1% |
| Q1 2023 | 10,877 | $1.06M | $97.27 | +43 | 0% |
| Q4 2022 | 10,834 | $1.12M | $103.47 | -466 | -4% |
| Q3 2022 | 11,300 | $958K | $84.78 | -269 | -2% |
| Q2 2022 | 11,569 | $959K | $82.89 | +11,569 | +100% |
| Q1 2022 | SOLD | — | — | -12,237 | -100% |
| Q4 2021 | 12,237 | $1.08M | $88.34 | -4,166 | -25% |
| Q3 2021 | 16,403 | $1.27M | $77.30 | +204 | +1% |
| Q2 2021 | 16,199 | $1.35M | $83.46 | +142 | +1% |
| Q1 2021 | 16,057 | $1.21M | $75.48 | -50,070 | -76% |
| Q4 2020 | 66,127 | $5.80M | $87.69 | -2,263 | -3% |
| Q3 2020 | 68,390 | $5.20M | $76.08 | +14,320 | +26% |
| Q2 2020 | 54,070 | $6.67M | $123.34 | -6,472 | -11% |
| Q1 2020 | 60,542 | $5.12M | $84.50 | +4,037 | +7% |
| Q4 2019 | 56,505 | $4.78M | $84.54 | -145,450 | -72% |
| Q3 2019 | 201,955 | $13.61M | $67.40 | +954 | 0% |
| Q2 2019 | 201,001 | $17.22M | $85.65 | -19,086 | -9% |
| Q1 2019 | 220,087 | $19.55M | $88.83 | -4,552 | -2% |
| Q4 2018 | 224,639 | $19.13M | $85.15 | -12,632 | -5% |
| Q3 2018 | 237,271 | $23.01M | $96.97 | -4,424 | -2% |
| Q2 2018 | 241,695 | $22.77M | $94.20 | -8,301 | -3% |
| Q1 2018 | 249,996 | $20.27M | $81.07 | +2,197 | +1% |
| Q4 2017 | 247,799 | $22.10M | $89.17 | +19,003 | +8% |
| Q3 2017 | 228,796 | $21.29M | $93.07 | +1,436 | +1% |
| Q2 2017 | 227,360 | $20.65M | $90.82 | -19,125 | -8% |
| Q1 2017 | 246,485 | $21.64M | $87.78 | -3,953 | -2% |
| Q4 2016 | 250,438 | $20.75M | $82.84 | +55,546 | +29% |
| Q3 2016 | 194,892 | $18.03M | $92.52 | -169,288 | -46% |
| Q2 2016 | 364,180 | $28.33M | $77.80 | -83,820 | -19% |
| Q1 2016 | 448,000 | $36.95M | $82.48 | +218,035 | +95% |
| Q4 2015 | 229,965 | $24.09M | $104.76 | +2,120 | +1% |
| Q3 2015 | 227,845 | $24.00M | $105.32 | -2,350 | -1% |
| Q2 2015 | 230,195 | $31.49M | $136.78 | -26,260 | -10% |
| Q1 2015 | 256,455 | $31.96M | $124.62 | -48,105 | -16% |
| Q4 2014 | 304,560 | $27.53M | $90.40 | -46,335 | -13% |
| Q3 2014 | 350,895 | $25.32M | $72.16 | — | NEW |